Internal Medicine · Jamaica, NY
NPI
1598163081
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
5
Medicare group memberships
Hospitals
1
Hospital affiliations
8914 Parsons Blvd
Jamaica, NY, 11432
Phone (718) 765-6358
Groups this clinician bills Medicare through
Medicare paid, 2024
$6,477
193 services
Medicare patients, 2024
36
Average age 66
Drug cost, 2024
$895K
4,986 prescriptions
Company payments, 2025
$20.6
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Qudsia Banu was code 96127 (behavioral health services), 82 times for 31 patients. In total Qudsia Banu billed 193 services in 14 codes, and Medicare paid $6,477.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96127 Behavioral Health Services | Office | 82 | 31 | $3.79 | $311 |
| 36415 Venipuncture Blood Collection | Office | 28 | 23 | $8.65 | $242 |
| 99213 Office E&M - Established | Office | 27 | 17 | $73.57 | $1,986 |
| 99214 Office E&M - Established | Office | 21 | 15 | $89.21 | $1,873 |
By year: 2022 $4,101 for 71 services; 2023 $6,271 for 96 services; 2024 $6,477 for 193 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 28 | 23 | $8.65 | $242 |
Medicare prescription drug claims, 2024
In 2024, the drug Qudsia Banu prescribed most often to Medicare patients was Atorvastatin Calcium, with 476 prescriptions and refills. In total Qudsia Banu wrote 4,986 Medicare prescriptions that cost $895K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 476 | 1,256 | 131 | $5,763 |
| Amlodipine Besylate Generic | 237 | 657 | 73 | $1,425 |
| Losartan Potassium Generic | 224 | 581 | 66 | $2,152 |
| Nifedipine Er Nifedipine | 174 | 482 | 47 | $4,919 |
| Metformin Hcl Generic | 172 | 440 | 52 | $1,090 |
| Gabapentin Generic | 164 | 227 | 39 | $1,276 |
| Jardiance Empagliflozin | 150 | 324 | 39 | $182K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 149 | 162 | 26 | $4,581 |
| Hydrochlorothiazide Generic | 139 | 401 | 46 | $383 |
| Metoprolol Succinate Generic | 138 | 326 | 37 | $2,467 |
| Ozempic Semaglutide | 133 | 178 | 26 | $154K |
| Alcohol Prep Pads Alcohol Antiseptic Pads | 119 | 157 | 33 | $947 |
| Chlorthalidone Generic | 87 | 235 | 23 | $2,056 |
| Levothyroxine Sodium Generic | 87 | 157 | 18 | $876 |
| Ammonium Lactate Generic | 81 | 85 | 26 | $1,053 |
Brand drugs: 1,114 claims; generic drugs: 3,466 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Qudsia Banu $20.6 ($20.6 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $20.6.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $20.6 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.